PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 152 filers reported holding PDL BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KESTREL INVESTMENT MANAGEMENT CORP | 1,634,000 | $4,804,000 | 1.81% |
| SMH CAPITAL ADVISORS INC | 80,722 | $237,000 | 0.37% |
| Matarin Capital Management, LLC | 1,126,641 | $3,312,325,000 | 0.25% |
| Hillsdale Investment Management Inc. | 337,800 | $993,000 | 0.14% |
| Zebra Capital Management LLC | 115,431 | $339,000 | 0.12% |
| Connor, Clark & Lunn Investment Management Ltd. | 4,789,702 | $14,082,000 | 0.08% |
| Fortis Advisors, LLC | 45,602 | $134,000 | 0.07% |
| Municipal Employees' Retirement System of Michigan | 500,080 | $1,470,000 | 0.07% |
| RBF Capital, LLC | 173,090 | $508,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 392,276 | $1,153,000 | 0.06% |